To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
595 Current news about the topic life sciencesrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses
Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlines our ...
German Accelerator announces the appointment of Marc Filerman as Chief Executive Officer of the Life Science program. Mr. Filerman is a highly experienced healthcare entrepreneur and venture consultant with a proven track record of launching and managing medical device, and diagnostic companies. ...
Startups can apply for programs at Merck headquarters in Darmstadt or in China
Merck announced that it has opened the next round of applications for startup companies to participate in the global Merck Accelerator program. Startups can choose to participate in one of the two programs, either at the company’s Innovation Center at global headquarters in Darmstadt or at its ...
The new DESY Innovation Village is the place for start-ups and innovative projects at DESY
“I Love Innovation” was the fitting motto with which the DESY Innovation Village was officially inaugurated on Valentine’s Day, in the presence of DESY’s Board of Directors and representatives of the federal and local Hamburg governments. It will offer DESY start-ups offices, workshops and ...
Investments from Swisscom Ventures & Zürcher Kantonalbank
Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 2.75Min seed fundingand gained Swisscom Ventures as a strategic investor. Zürcher Kantonalbank also joined the financing round, alongside the existing shareholders, thus reaffirming ...
Company signed agreement with Guangzhou Development District
Merck signed an agreement with the Guangzhou Development District on innovation development in Southern China. Pursuant to this agreement, Merck will establish an innovation hub in Guangzhou scheduled to open September 2019. “China is a major innovation hotspot and one of our most important ...
Funding of up to € 350,000 per research grant or up to € 30,000 per research challenge
Merck announced several research grants and challenges during the company’s 350th anniversary year in addition to already existing initiatives. The new research grants and challenges are mainly directed to scientists working in institutes, universities or start-up companies around the world. “The ...
Danaher Corporation and Integrated DNA Technologies announced that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing ...
SYGNIS AG announced its subsidiaries Innova Biosciences, Expedeon Holdings, and C.B.S. Scientific have united as Expedeon, effective 1 March 2018. The corporate rebranding follows the latest acquisition of Innova Biosciences by SYGNIS AG in June 2017. SYGNIS AG will continue to serve as the ...
Also announces CRISPR-patent allowances in Israel and South Korea
Merck announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel. For this purpose the strategic corporate venture capital arm of Merck has partnered with Arkin Holdings, Pontifax and WuXi AppTec to ...